Representing Mylan in ANDA litigations over the generic version of Dyloject®. The case involves two patents and is tentatively set for trial in April 2018.

Janssen Pharmaceuticals, Inc, et al. v. Mylan Laboratories Limited, et al., No. 16-224 (D. Del. filed April 4, 2016) and Janssen Pharmaceuticals, Inc., et al. v. Mylan Laboratories Limited, et al., No. 16-59 (N.D. filed April 6, 2016).

Experience Center

Match our Experience to Your Needs

Experience Highlights

Convinced DOJ not to take action in a theft of trade secret investigation
In less than three months, we convinced the Department of Justice not to take any action against a client employee for allegedly stealing trade more
Procter & Gamble Co. v. Georgia-Pacific Consumer Products LP
Served as lead counsel for Georgia-Pacific Consumer Products LP in the defense of our client against a trademark infringement suit. The more
Griffin v. Harley-Davidson Credit Corp. and Eaglemark Savings Bank
Represented Harley-Davidson Credit Corp. and Eaglemark Savings Bank in this putative class action filed in the United States District Court for the more
Securities counsel to Internet Security Systems Inc. in connection with its $1.3 billion acquisition by IBM
Served as securities counsel to Internet Security Systems Inc. in connection with its $1.3 billion acquisition by IBM. more